HEXA-GERM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hexa-germ, and when can generic versions of Hexa-germ launch?
Hexa-germ is a drug marketed by Huntington Labs and is included in one NDA.
The generic ingredient in HEXA-GERM is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
Summary for HEXA-GERM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 3,375 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEXA-GERM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HEXA-GERM
US Patents and Regulatory Information for HEXA-GERM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Huntington Labs | HEXA-GERM | hexachlorophene | EMULSION;TOPICAL | 017411-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |